Native homing endonucleases can target conserved genes in humans and in animal models by Barzel, Adi et al.
Native homing endonucleases can target conserved
genes in humans and in animal models
Adi Barzel
1,2,*, Eyal Privman
3,4, Michael Peeri
3, Adit Naor
1, Einat Shachar
1,
David Burstein
3, Rona Lazary
1, Uri Gophna
1, Tal Pupko
3,5 and Martin Kupiec
1
1Department of Molecular Microbiology and Biotechnology, Tel Aviv University, Ramat Aviv 69978, Israel,
2Department of Pediatrics and Genetics, Stanford University School of Medicine, Stanford, CA 94305-5164,
USA,
3Department of Cell Research and Immunology, Tel Aviv University, Ramat Aviv 69978, Israel,
4Department of Ecology and Evolution, University of Lausanne, 1015 Lausanne, Switzerland and
5National Evolutionary Synthesis Center, 2024 W. Main Street A200, Durham, NC 27705, USA
Received November 25, 2010; Revised March 31, 2011; Accepted April 5, 2011
ABSTRACT
In recent years, both homing endonucleases
(HEases) and zinc-finger nucleases (ZFNs) have
been engineered and selected for the targeting of
desired human loci for gene therapy. However,
enzyme engineering is lengthy and expensive and
the off-target effect of the manufactured endonucle-
ases is difficult to predict. Moreover, enzymes
selected to cleave a human DNA locus may not
cleave the homologous locus in the genome of
animal models because of sequence divergence,
thus hampering attempts to assess the in vivo
efficacy and safety of any engineered enzyme prior
to its application in human trials. Here, we show that
naturally occurring HEases can be found, that
cleave desirable human targets. Some of these
enzymes are also shown to cleave the homologous
sequence in the genome of animal models. In
addition, the distribution of off-target effects may
be more predictable for native HEases. Based on
our experimental observations, we present the
HomeBase algorithm, database and web server
that allow a high-throughput computational search
and assignment of HEases for the targeting of
specific loci in the human and other genomes.
We validate experimentally the predicted target spe-
cificity of candidate fungal, bacterial and archaeal
HEases using cell free, yeast and archaeal assays.
INTRODUCTION
Gene targeting, the site-speciﬁc manipulation of the
genome, is the holy grail of gene therapy and genetic
engineering. It promises to markedly reduce the risks
associated with viral vector-mediated gene insertion,
most notably, the risks of induced oncogene
overexpression and insertional mutagenesis (1). Gene
manipulation at a locus of choice is best facilitated by
the introduction of a site-speciﬁc double-stranded DNA
break (DSB). The default repair of the DSB by non-
homologous end joining (NHEJ) can lead to gene disrup-
tion. In the presence of an appropriate donor template, the
break can be repaired by homologous recombination
(HR) leading to gene correction or gene insertion at the
desired locus. Indeed, in recent years, much effort has
been invested in the engineering of site-speciﬁc DNA
endonucleases that can cleave desired loci in the human
genome and induce gene targeting. Impressive results
came from the use of zinc-ﬁnger nucleases (ZFNs),
chimeric enzymes consisting of an endonuclease domain
that is artiﬁcially linked to a site-speciﬁc array of zinc-
ﬁnger domains (2). Of special note is the use of ZFNs
engineered for the speciﬁc ex vivo disruption of the HIV
coreceptor CCR5 in the T lymphocytes of AIDS patients,
now under clinical trials (3) (see: http://clinicaltrials.gov/
ct2/show/NCT00842634). Another promising option is
presented by meganucleases, engineered homing endo-
nucleases, selected to cleave a locus of choice [e.g. XPC
(4), RAG (5)]. ZFNs and meganucleases have also been
used in crop bio-engineering (6), in the production of
model cell lines (7,8) animal models (9), induced pluripo-
tent stem cells (10,11) and more.
The obvious advantage of using engineered endo-
nucleases is the ability to target almost any gene of
choice. However, the production of site-speciﬁc ZFNs
and meganucleases is burdensome, lengthy and expensive.
Moreover, the rate and distribution of off-target cleavage
for these enzymes is difﬁcult to predict (12). Importantly,
safety assessments for engineered endonucleases are
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human locus will seldom cleave the homologous gene of
an animal model because of sequence divergence. Here we
show that native homing endonucleases (HEases), with
their predictable target range and conservation of target
sites in animal models, may present a promising alterna-
tive to engineered endonucleases for gene targeting.
HEases are a large and diverse class of site-speciﬁc
nucleases found in Archaea, Bacteria and Eukarya and
in their respective viruses (13,14). HEase genes (HEGs)
are selﬁsh genetic elements that reside as open reading
frames (ORF) within self-splicing introns or as an endo-
nuclease domain within inteins (15). An HEase promotes
the horizontal propagation of its respective intron/intein
into an intron-less or intein-less allele by cleaving the
vacant allele to induce HR or reverse transcription,
which results in effectively copying the intron/intein
together with the HEG into the same position in the
vacant allele (Figure 1). Importantly for their use in
gene therapy, HEases possess the ability to introduce
highly speciﬁc breaks in the human genome due to their
long target sequences (14–40bp). Indeed, native HEases
are able to induce either site-speciﬁc NHEJ or site-speciﬁc
HR in mammalian genomes engineered so as to contain
the HEase’s target site (16–19). However, native HEases
have not been used for gene therapy to date, probably
because of the common misperception that they have no
targets in the human genome. Instead, as mentioned
above, selected HEases were subjected to rational engin-
eering and directed evolution, so that they could target
disease-associated genes (4,20). Nevertheless, basic
research into native HEases has revealed some features
with implications for their potential use in gene therapy.
Importantly, the target sites of HEases are not strin-
gently deﬁned: some nucleotides along the target site can
be substituted while cleavage efﬁciency is retained (21).
Without a general way to predict the plasticity in HEase
target recognition, it might have been very difﬁcult to
apply HEases as tools for gene therapy. However,
accumulating evidence suggests that HEase plasticity is,
at least to some extent, predictable based on the
evolutionary considerations (22–26). It has long been
appreciated that inteins and self-splicing introns tend to
be found in conserved motifs of essential genes (27).
Hence, any partial or inaccurate intron/intein deletion or
mutation at a splicing motif is detrimental to the host,
which is left with a persistent disruption in a critical
gene. The self-serving localization of the intron/intein is
also beneﬁcial for the HEase. An HEase promotes the
copying of its respective intron/intein into its target site
and therefore, HEase targets coincide with intron/intein
insertion sites (Figure 1). In particular, a conserved inser-
tion site is also a conserved HEase target site. Therefore,
the host cannot easily evade the parasite by altering the
target sequence.
Nevertheless, even highly conserved loci usually include
some variable sites. HEases have therefore evolved so that
they rely on conserved positions within the target sequence
for robust target recognition (24–26). In particular, when
the hosting gene encodes a protein, selection on this gene
acts mainly to conserve its amino acid translation rather
than the coding nucleotide sequence. Synonymous substi-
tutions are therefore frequent even in sequences coding
conserved protein motifs. Thus, HEases are expected to
evolve tolerance to silent target mutations. Indeed,
Kurokawa et al. (22) have demonstrated for an array of
intron-encoded HEases residing in protein-coding genes,
that single silent mutations in the target sites are far better
tolerated than mutations that alter the coded polypeptide.
Scalley-Kim et al. (23) have examined the speciﬁcity
proﬁle of the I-AniI HEase and found it to be strongly
correlated with wobble versus non-wobble positions and
also with the degree of degeneracy inherent in individual
codons. At the focus of the above studies were HEases of
the LAGLIDADG family, which is the most abundant
structural family of HEases. However, similar evolution-
ary considerations may apply to the binding and cleavage
speciﬁcity of GIY–YIG HEases (28,29) which have a
highly distinct mode of DNA interaction.
In this work, we reasoned that the predictability of
HEase target recognition may allow the discovery of
formerly unidentiﬁed HEase targets in the human and
other genomes, for the beneﬁt of gene therapy and
genetic engineering. We ﬁrst demonstrate that HEases
residing in protein-coding genes are often tolerant of con-
comitant synonymous substitutions at all wobble pos-
itions in their target site. This is a generalization of
previous reports (22–26) that allows ﬁnding HEase
targets in formerly unidentiﬁed loci in the human and
other genomes. To apply this principle to as many
HEases as possible, we searched all public sequence data-
bases for novel HEGs. At this stage, we relied on another
property of naturally occurring HEGs, which is that the
gene coding the enzyme and the target sequence of
HEase target
HEG
Intein or intron
Hosting gene
A HEG in a
hosting gene
Vacant homolog
HEG
HEG
HEG
Recombination
Homing Endonuclease
Figure 1. The Homing process. The homing endonuclease (HEase) is
expressed from the HEG (red), residing in an intron or as an in-frame
domain of an intein (purple) in a hosting gene (cyan). It cleaves the
target site (orange) in a vacant homolog of the hosting gene to induce
homologous recombination (gene conversion or double crossover),
turning the vacant homolog into a HEG-carrying one.
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target sequence ﬂanks the intron/intein insertion site
(Figure 1). This property allowed us to predict a
putative target sequence for each newly discovered
HEase. The results of this search were compiled in the
form of the HomeBase database. Finally, we experimen-
tally validated the predicted speciﬁcity range of candidate
fungal, bacterial and archaeal HEases using cell-free, yeast
and archaeal assays. Thereby, a large arsenal of naturally
occurring HEases was compiled together with their pre-
dicted target ranges, providing a diverse toolbox of
speciﬁc cutters for the genetic manipulation of large and
complex genomes.
MATERIALS AND METHODS
Experimental methods
Strains, plasmids and oligonucleotides. Supplementary
Table S1 lists the strains, plasmids, oligonucleotides and
PCR primers used in this study. For extra-cellular
cleavage assays we inserted the native, mutated or
predicted target-sites of PI-SceI and PI-PspI into
pGEM-Teasy (Promega, Figure 2a and b) or into the
PfoI site of pDELT (Figure 2d). pDELT was constructed
by cleaving pRS304 (30) with SmaI and inserting a 427bp
long PCR segment of the Saccharomyces cerevisiae LYS2
gene, ampliﬁed using the OI3 and B82 primers.
The archaeal homing assay was conducted using the
Haloferax volcanii strain WR532 (H133) DpyrE2 (31).
The Archaea were transformed with either the pTA131
(32) or the pTA1.1 plasmids, or the pTA1.1hum plasmid.
pTA1.1 and pTA1.1hum are derivatives of pTA131.
pTA1.1 carries between the EcoRI and SpeI sites a 1.1kb
long PCR segment of H. volcanii POLB gene lacking the
POLB intein (33) that was ampliﬁed using the Hvol 1.1F
and R primers. The pTA1.1hum carries a similar segment
in which a BmgBI fragment including the native target of
the POLB HEase was replaced by a fragment carrying the
predicted human target.
The S. cerevisiae strains used for the yeast HEase assay
are all derivatives of OI50 (Supplementary Table S1).
In the following explanation about the construction of
the derivatives, X stands for either one of: (i) Botrytis
cinerea PRP8 HEase native target; (ii) The B. cinerea
PRP8 HEase predicted human target; (iii) The B. cinerea
PRP8 HEase predicted mouse target; (iv) Nostoc RNR
HEase native target; (v) Nostoc RNR HEase predicted
N. punctiforme target; (vi) Nostoc RNR HEase predicted
Synechococcus target. Yeast strains with YDEUH preﬁx
(YDEUH+X target) were constructed by transform-
ing OI50 with NcoI-cleaved pDEUH derivatives
(pDEUH+X target). pDEUH is pRS303 (30) carrying a
315-bp long PCR segment of the S. cerevisiae URA3 gene
(ampliﬁed using the OI5 and B45 PCR primers) at its
HincII site. The pDEUH derivatives each have a different
HEase target at the PfoI site of pDEUH. Yeast strains
with YDELT preﬁx (YDELT+X target) were constructed
by transforming OI50 with HpaI-cleaved pDELT deriva-
tives (pDELT+X target). The pDELT derivatives each
have a different HEase target in the PfoI site of
pDEUH. As explained above, pDELT is pRS304 (30)
carrying a 427-bp long PCR segment of the S. cerevisiae
LYS2 gene.
Yeast strains with YDEUHLT preﬁx (YDEUHLT+X
targets) were constructed by transforming YDEUH+X
target with HpaI-cut pDELT+X target. Final constructs
of the form: YDEUHLT+X target+pGML+Y HEase,
were constructed by transforming YDEUHLT+X targets
with a pGML10 (34) derivative encoding the Y HEase
(either B. cinerea PRP8 HEase or Nostoc RNR HEase).
The B. cinerea PRP8 HEase was ampliﬁed from the
B. cinerea strain B05.10, a kind gift from Professor
Annika Bokor (35), using the primers: B. cinerea-HEN-
F and R. The forward primer includes an ATG start
codon and an SV40 nuclear localization signal (NLS).
The ampliﬁed B. cinerea PRP8 HEase was inserted
between the XbaI and XmaI sites of pGML10. The
Nostoc RNR HEase was ampliﬁed from Nostoc
(Anabaena) sp. PCC 7120, a kind gift from Professor
Sammy Boussiba (36), using the primers: Nostoc-HEN-F
and R. Here again, the forward primer includes an ATG
start codon and an SV40 NLS. The ampliﬁed Nostoc
RNR HEase was inserted between the BamHI and
EcoRI sites of pGML10.
Extra-cellular cleavage assays. A quantity of 1mgo fa
plasmid [pGEM derivative (Figure 2a and b) or pDELT
derivative (Figure 2d)] carrying a native, mutated or
predicted target of PI-SceI (Figure 2a and d) or PI-PspI
(Figure 2b) were subjected to cleavage using 1 U of each
enzyme as provided by New Englands Biolabs (at
29pmol/U for PI-SceI and 80fmol/U for PI-PspI), in
a5 0 ml reaction at 37 C (PI-SceI) or 65 C (PI-PspI).
Aliquots were extracted every 30min (Figure 2a), 15min
(Figure 2b) or after a 16h over-night incubation (Figure
2d). PI-SceI was heat-inactivated (20min, 65 C) and all
samples were fragmented by a restriction endonuclease
[BspHI (Figure 2a and b) or XbaI (Figure 2d) for 1h in
a1 0ml reaction] prior to gel elecrophoresis.
Archaeal homing assay. For the transformation of
H. volcanii a liquid culture (1.5ml; OD600nm of 1.5) was
centrifuged at 3500g for 5min. The supernatant was dis-
carded, the cells were resuspended in 200ml spheroplasting
solution (1M NaCl, 27mM KCl, 50mM Tris–HCl pH
8.2, 15% sucrose) and incubated at room temperature
for 5min. A quantity of 20ml of 0.5M EDTA was
added and cells were incubated at room temperature for
10min. Then, 10ml of puriﬁed plasmid DNA was mixed
with 15ml spheroplasting solution and 5ml of 0.5M EDTA
was added to the cells, followed by incubation of 5min at
room temperature. Subsequently, 240ml of PEG solution
(60% PEG 600 in spheroplasting solution) was added and
cells were incubated for an additional 20min at room tem-
perature. Following the incubation, 1ml of regeneration
solution (3.4M NaCl, 175mM MgSO4, 34mM KCl,
5mM CaCl2, 50mM Tris–HCl pH 7.2, 15% sucrose)
was added and cells were centrifuged at 3500g for 7min.
The supernatant was discarded and cells were resuspended
in HY medium supplemented with 15% sucrose and left to
incubate without shaking overnight at 37 C. The cultures
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The presence of an intein on the exogenic plasmids indi-
cates that homing has taken place and in particular that
efﬁcient cleavage has occurred. Intein presence was tested
by PCR using the RP2 and M13F primers. The standard
errors were calculated based on a binomial distribution
with an added pseudo-count of 0.5 successes and 0.5
failures.
Yeast HEase assay. Prior to the recombination assay,
dilutions of four independent colonies of each strain
were plated on YEPD medium (1% yeast extract, 2%
Bacto Peptone, 2% dextrose, 2% Bacto-agar) and on
YEP-GAL medium (1% yeast extract, 2% Bacto
Peptone, 2% galactose, 2% Bacto-agar) in order to
assess the toxicity of each enzyme (Supplementary
Figure S3). For the recombination assay, each of the
four colonies of each strain was grown overnight at
30 C in a synthetic complete (SC) liquid medium supple-
mented with 2% galactose (for strains without an HEase
expression plasmid), or SC-Leucine liquid medium
supplemented with 2% galactose (for strains with an
HEase expression plasmid, marked with the LEU2
gene). Cells were then pelleted, diluted and plated on
YEPD and on SD-Ura (synthetic complete medium  
uracil+2% dextrose+2% bacto-agar) and SD-Ura-Lys
(synthetic complete medium   uracil   lysine+2%
dextrose+2% bacto-agar) to assess recombination rate
(implying HEase activity rate). HEase activity rate is
deﬁned as the average fold increase in colony formation
on the selective medium of the strain with target X and
HEase Y with respect to the average colony formation on
the selective medium of the strains without any HEase.
The conﬁdence intervals for the fold increase were
calculated by Monte Carlo sampling of pairs of simulated
measurements from two normal distributions having the
same mean and variance as the actual measurements.
The 95% conﬁdence intervals used are the 2.5th and
97.5th quantiles of the emerging distribution of ratios.
Construction of the HomeBase HEase database
Search for HEGs in DNA databases (BLAST-1). A
homology search for novel HEGs was conducted across
all available DNA data sets. A set of known HEGs was
used as queries for BLAST searches. Protein sequences of
known HEases in introns and inteins were retrieved from
manually curated databases. A total of 289 sequences of
HEGs in Group I introns were downloaded from the
Group I Intron Sequence and Structure Database (37)
(GISSD; http://www.rna.whu.edu.cn/gissd). Three
hundred twenty ﬁve sequences of HEGs in inteins were
downloaded from INBASE (38) (http://www.neb.com/
neb/inteins.html). In both introns and inteins, the
manual curation of these databases ensures that these
protein sequences do not include exonic or exteinic
parts. This is essential for our purpose because otherwise
the BLAST searches will retrieve many homologs of the
hosting gene instead of novel HEGs. This sequence set,
totaling 614 HEGs will be subsequently referred to as the
‘known HEGs set’. Using translated BLAST (tblastn), the
known HEase protein sequences were used as queries to
search against all possible six frames translations of the
non-redundant nucleotide database nt and the
non-redundant environmental (metagenomic) nucleotide
database env_nt, both downloaded from the NCBI web
site (http://www.ncbi.nlm.nih.gov/ftp/). We retained all
hits of E-value<10. This stage will be subsequently
referred to as BLAST-1.
For each hit sequence in the BLAST-1 results there are
often several high scoring pairs (HSPs), pairwise align-
ments of a query subsequence to a hit subsequence
(which is translated in one of the six possible reading
frames). Furthermore, a novel HEG sequence is usually
homologous to several of the known HEGs, therefore
several queries yield overlapping HSPs in the same hit
locus. The number of HSPs per hit sequence is often
large for whole chromosome sequences, which may
contain several loci of HEase homology. To divide such
hit sequences to distinct loci, all HSPs from all queries on
the same hit sequence were clustered. Overlapping and
neighboring HSPs <2000 bases apart, were clustered and
1000 bases were added on either side of every cluster.
These hit subsequences are the putative novel HEGs and
their adjacent intron/intein and exon/extein sequences.
This procedure often resulted in a cluster of several
HEG-containing intron/inteins in the same host gene.
Deﬁning splice sites (HEase target sites) based on vacant
homologs (BLAST-2). For any gene that harbors a HEG
inside an intron/intein, a vacant homolog is a homologous
sequence of that gene without the intron/intein. A second
BLAST search was conducted for each putative
HEG-containing sequence in order to identify such a
vacant homolog. Each subsequence resulting from the
clustering of the BLAST-1 HSPs was used as the query
for the second BLAST search, hereby termed BLAST-2.
In this translated BLAST (tblastx) each of the three
possible translations of the strand that was aligned to
the known HEG in BLAST-1 was searched against the
same non-redundant DNA databases as above. Each
BLAST-2 hit was checked for several criteria to determine
if it contained a bona ﬁde vacant homolog (Supplementary
List S1). After identifying the ﬁrst intron/intein in the
BLAST-2 query, we repeated the procedure using only
BLAST-1 HSPs that do not overlap the intron/intein.
Only BLAST-2 HSP pairs that contain these BLAST-1
HSPs were considered as potentially deﬁning introns/
inteins. Thereby, several additional non-overlapping
introns/inteins were often identiﬁed in the same
BLAST-2 query until no BLAST-1 HSPs remained.
The ﬁnal outputs of the algorithm are the target
sequence ﬂanking these splice sites in the query (the
pHEG-containing sequence) and the ORF of the HEase
(in introns) or of the intein, which codes for the HEase.
This output constitutes the HomeBase database.
To assess the accuracy of prediction, we sampled 30
putative HEGs and manually inspected all stages of the
automatic pipeline, including: conﬁdence in the BLAST-1
homology and conservation of known HEase motifs; con-
ﬁdence and accuracy of the BLAST-2 alignment to the
vacant homology, especially of the exon/extein boundaries
Nucleic Acids Research, 2011,Vol.39, No. 15 6649after correction of gaps/overlaps (where possible we
compared the prediction to annotation of intron
position and intron/intein splice sites consensus).
We found 92±4% (mean±SE) of the results to have
reliable homology to a known HEG and 75±7% to be
true HEGs with correct identiﬁcation of the target site.
For the 222 results of the second iteration, we estimate
an accuracy level of 25±7%. The overall number of
known HEGs was estimated by querying all protein
records available in the Entrez engine. The search term
used was ‘homing endonuclease’ [All Fields] NOT
txid33208 [Organism:exp]. (33208 is the taxonomy identi-
ﬁer for Metazoa). The number of predicted HEGs that
were previously annotated as HEGs was determined by
checking the GenBank records containing them. All
CDS features overlapping the containing intron/intein
were examined. In addition, if a CDS contained a
‘protein_id’ tag, the corresponding GenPept record was
obtained through Entrez and all features found were
included in the search. For all the features selected, the
text of the following tags was examined: ‘note’, ‘product’,
‘gene’, ‘gene_synonym’ for CDS features and ‘note’,
‘region_name’ and ‘product’ for features found in the
protein. A HEG was considered to be previously
annotated if any of the tags contained the term ‘homing
endonuclease’.
The HomeBase database. The HomeBase database is the
uniﬁed set of HEGs including our novel predictions and
the known HEGs from INBASE and GISSD. To infer the
target sequences from these databases, we download the
exon or extein sequences from INBASE or GISSD
respectively and extracted the ﬁrst seven amino acids
from each exon/extein.
We classiﬁed HomeBase records into HEG families by
homology (blastp) of the translated ORF of the putative
HEG against a set of HEG sequences with family anno-
tation collected from the INBASE, GISSD and Entrez
Protein databases. This set includes representatives from
the LAGLIDADG, HNH, GIY–YIG and His–Cys
families. Each HomeBase HEG was assigned the family
annotation of the top BLAST hit, except in ambiguous
cases where the top hit from a different family had
an E-value that was close to the top hit E-value by a
factor <10.
Identifying candidate HEases for speciﬁc targets. To reveal
the potential utility of the HomeBase collection for genetic
intervention in humans, we used translated BLAST
(tblastn) to search for a match between the translations
of HomeBase target sequences and all possible six-frame
translations of the human genome. Resulting hits were
sorted by their similarity. We also required that ﬁve out
of the six central residues be identical and that the sixth
residue be at least similar. We classiﬁed the hits as genic or
intergenic depending on whether or not they reside within
an annotated gene or the 5000 bases ﬂanking it (ftp://ftp
.ncbi.nih.gov/gene/DATA/gene2accession.gz).
Furthermore, we classiﬁed genic hits into coding exons
versus non-coding introns and ﬂanking sequence (ftp://
ftp.ncbi.nih.gov/genomes/H_sapiens/mapview/seq_gene.
md.gz) to identify hits that may be the result of true
protein homology (Supplementary Table S2). To
estimate the number of off-target hits for each HEase in
the human genome, we counted the number of BLAST
hits whose E-value is three times worse (larger) than the
E-value of the top hit.
RESULTS
Native HEases can efﬁciently cleave targets with
concomitant silent mutations at all wobble positions
It has previously been shown that HEases encoded by
genes residing in introns/inteins of protein-coding genes
can cleave variants of their target sites bearing single or
a few synonymous substitutions (22,23). Here, we demon-
strate that at least some HEases can efﬁciently cleave
targets with concomitant silent mutations in all codons
of the target sequence. This is a result of the evolutionary
history of the HEases and their hosts: mutations in the
target site that prevent insertion of the intron/intein
would be advantageous for the host, however, as most
molecular parasites occupy critical positions within
essential genes, most mutations of this sort are lethal
and only silent mutations are tolerated. HEases thus
adapted by being able to cut variants of the target site
carrying synonymous substitutions. The far-reaching
implication of this ﬁnding is that one can use translated
BLAST and ﬁnd many formerly unidentiﬁed HEase
targets in the human and other genomes (see below).
To demonstrate this general principle, we examined the
target speciﬁcity of HEases stemming from two different
domains of life: PI-SceI, an HEase from the yeast
S. cerevisiae and PI-PspI from the archaeon Pyrococcus
species GB-D. We assessed the cleavage efﬁciency of these
HEases on their native targets as well as on targets where
all wobble positions underwent transitions. Both enzymes
were found to cleave a target bearing 10 (PI-PspI) or 11
(PI-SceI) silent mutations even better than they do their
original target, while a single non-silent substitution com-
pletely eliminated cleavage by PI-SceI and reduced
cleavage by PI-PspI (Figure 2a and b). Tolerance of
wobble substitutions does not imply promiscuity.
Cleavage by PI-SceI is almost completely prevented by
non-synonymous substitutions in any one of nine different
positions along its target (21). Thus, HEase target recog-
nition combines tolerance for mutations in synonymous
positions with increased speciﬁcity for the non-
synonymous positions. [albeit restricted; e.g. tolerance to
some non-synonymous substitutions (21,23), Figure 2b].
Our results imply that HEases residing in protein-
coding genes can cleave many DNA sequences having
the same translation as their native target. This increases
the odds of ﬁnding an HEase that can cleave any
disease-associated gene or pre-speciﬁed genomic safe
harbor by several orders of magnitude. For example,
a 24-bp long DNA sequence is found at random every
4
24&3*10
14bp while its eight amino acid long translation
is found at random every 20
8 & 2.5*10
10 codons. It is
therefore expected that within a large enough array of
HEases at least some will be found able to cleave the
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C. Jacchus
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M. musculus
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G. gallus
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ase HEase
R. norvegicus
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-ase HEase
D. rerio
G
ATCTATGTCGGGTGCGGAGAAAGAGGTAATGAA TGGCAAACAGCTATTATGGGTATTATGGGTA
I  Y  V  G  C  G  E  R  G  N  E
ATTTACGTTGGATGTGGGGAGAGGGGCAACGAG
L  A  N  S  Y  Y G  Y  Y G  Y
TAGCGAATAGTTACTACGGATACTACGGATA
A
(a)
(c)
(d)
(b) PI-SceI PI-PspI
PI-SceI
ATCTATGTCGGGTGCGGAGAAAGAGGTAATGAA
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Figure 2. Characterization of HEase plasticity in target recognition and its use for ﬁnding HEase targets in the human and other genomes. (a) and
(b): HEase cleavage is tolerant of concomitant mutations at all wobble positions along the target site. The cleavage efﬁciency of the HEases PI-SceI
(from S. cerevisiae) (a) and PI-PspI (from Pyrococcus species GB-D) (b) was assayed on different targets cloned on a bacterial plasmid. The cloned
vectors were then fragmented by a restriction enzyme for the sake of visual clarity. Both HEases cleave targets mutated at all wobble positions (top
DNA sequence) with higher efﬁciency than they cleave their native targets (bottom DNA sequence). Conversely, a single non-synonymous mutation
(red arrow) is sometimes sufﬁcient to abolish cleavage by PI-SceI and to reduce cleavage by PI-PspI. (c) and (d): PI-SceI can cleave its predicted
targets from the human ATP6V1A1 gene and its homologs in the genomes of animal models. (c) Alignment of the native target of the PI-SceI HEase
from S. cerevisiae with the predicted targets in the human ATP6V1A1 gene and its homologs in the genomes of animal models. (d) Results of an
in vitro cleavage assay demonstrating that PI-SceI can cleave its predicted targets from the genomes of diverse organisms. UC, uncut; RE, cut by a
restriction enzyme (XbaI); HEase, cut by an HEase, RE+HEase, cut by XbaI AND by PI-SceI. S. cerevisiae, Saccharomyces cerevisiae; H. sapiens,
Homo sapiens; C. familiaris, Canis familiaris; C. jacchus, Callithrix jacchus; M. musculus, Mus musculus; G. gallus, Gallus Gallus; R. norvegicus, Rattus
norvegicus; D. rerio, Danio rerio.
Nucleic Acids Research, 2011,Vol.39, No. 15 6651human genome at desired loci. Furthermore, we recall that
HEGs reside within introns or inteins found in conserved
motifs. Therefore, in many instances, ﬁnding an HEase
target in the human genome is not a random event but
rather a result of evolutionary motif conservation from
the HEase hosting microbe to humans. For example, the
PI-SceI HEase originates from an intein lying in the
vacuolar membrane ATPase (VMA) gene of the budding
yeast S. cerevisiae. The S. cerevisiae VMA is a homolog of
the human vacuolar ATPase ATP6V1A1 and has a high
degree of sequence similarity in the regions ﬂanking the
PI-SceI-intein insertion site (Figure 2c; note that the intein
is present only in the yeast—there are no inteins in
humans). Indeed, PI-SceI can speciﬁcally cleave a
PCR-ampliﬁed segment of the human ATP6V1A1 locus
including the predicted target (Figure 2d). We note that
vacuolar ATPases are recognized as a potential therapeut-
ic target for the treatment of osteoporosis (39). In particu-
lar, the vacuolar ATPase inhibitor, FR167356, has been
shown to prevent bone resorption in ovariectomized rats
(40). It is, therefore, implied that PI-SceI may be used for
ATP6V1A1 disruption in desired tissues. Moreover,
because the target recognition of native HEases is based
on evolutionary conservation, we predicted that PI-SceI
would be able to cleave not only the human ATP6V1A1
but also the ATPase gene homologs in animal models
(Figure 2c), thus facilitating pre-clinical efﬁcacy and
safety assessments. We cloned the predicted target from
different animals in a bacterial plasmid and subjected the
vector to PI-SceI cleavage. We observed efﬁcient cleavage
of all ATP6V1A1 homologs by PI-SceI (Figure 2d).
Construction of HomeBase, the HEase database
Acknowledging the potential applicability of native
HEases, we set out to develop a high-throughput
approach for the detection of HEGs in sequence databases
and the prediction of HEase targets in the human and
other genomes. Our algorithm for the construction
of the ‘HomeBase’ HEase database is depicted in
Figure 3a. As a crude ﬁrst step, we used manually
(a)
(b)
(c)( d)
Figure 3. The HomeBase algorithm and database. (a) Database construction involves: (i) the identiﬁcation of putative HEGs in both genomic and
meta-genomic databanks using translated BLAST searches; (ii) The identiﬁcation of vacant homologs using a second translated BLAST; (iii) The
identiﬁcation of exon boundaries and the prediction of the target based on the vacant homologs and the translation of the target to deﬁne the target
range. The HomeBase database consists of a set of HEG sequences and the predicted target range of each HEase. The user may then query
HomeBase with (e.g.) a human gene of interest and receive a list of HEases, which are predicted to cleave the query sequence based on a translated
BLAST search against the targets in the database. (b) Statistics of the HomeBase database. (c) A pie diagram depicting the percentage of previously
annotated versus newly discovered HEGs within the results of the HomeBase algorithm. (d) Classiﬁcation of HomeBase HEGs into structural
families.
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INBASE and GISSD databases) as queries in a translated
BLAST to ﬁnd putative HEGs in the genomic and
metagenomic DNA databanks (metagenomic DNA
databanks hold DNA sequences of uncultured organisms,
mostly from environmental samples). This BLAST search
is conducted with a very permissive similarity threshold
(E-value<10).
We next used several ﬁlters to separate true HEGs from
false hits. First, we screened for a feature that is unique to
HEGs—the presence of a vacant homolog—deﬁned as a
homolog of the HEG-hosting gene that lacks the intron or
intein in the respective locus (Figure 1). HEG-hosting
genes are expected to have vacant homologs because the
phylogenetic distribution of mobile introns and inteins is
typically non-monophyletic (41,42); if a certain gene in a
certain species codes a mobile intron, it is highly probable
that there exists a related species in which the homologous
gene is intronless. Conversely, any false hit of the initial
BLAST search that is not encoded in an intron or an
intein will be excluded for lack of a vacant homolog.
HEG-less introns and inteins may have vacant
homologs, but these were excluded for being shorter
than a pre-determined length threshold (see ‘Materials
and Methods’ section). These ﬁlters allowed us to use a
very low homology threshold in search for novel genes,
while keeping the frequency of false hits relatively low
(Figure 3b and c). Thereby many highly divergent novel
HEGs can be discovered. HEGs residing in non-coding
RNA genes were excluded from HomeBase because their
target plasticity is not based on synonymous/
non-synonymous positions.
Using this method we have been able to ﬁnd 684 HEGs
(Figure 3b and c), 70% of which have not been annotated
before as HEGs (60% in sequenced genomes and 10% in
metagenomic sequences). In a manual inspection of a
random sample of 30 predictions we found 75±7%
(mean±SE) to be true HEGs with correct identiﬁcation
of the target site (see ‘Materials and Methods’ section).
We then complemented our original data with those of
others (37,38,43) to conclude with a ﬁnal database of ap-
proximately a thousand distinct HEGs. To facilitate the
applicability of our database, we developed a web-server,
which allows one to search a DNA sequence of choice
(e.g. a human gene) for putative targets of HEases. The
web-server can be freely accessed at: http://homebase-
search.tau.ac.il/.
The signiﬁcant addition of novel HEGs to the set of
known HEGs can be used to expand the query set of the
HomeBase algorithm. We conducted a second iteration
of the entire pipeline using the union of the original
query set with the 684 HEase-coding sequences that
were identiﬁed in the ﬁrst iteration of HomeBase. This
procedure extended the predictions by 222 additional
HEGs (Figure 3b) demonstrating that the potential of
novel HEGs in the extant sequence databases has not
yet been exhausted. We nevertheless hold the results of
the second iteration as a distinct set and not united with
our initial 684 results, because, as can be expected, we
observed signiﬁcantly lower prediction accuracy after the
iterative process (See ‘Materials and Methods’ section).
We note that the NCBI database holds 1386 sequences
annotated as HEGs, only 213 of which (15%) were
retrieved by our algorithm. This is expected because of
our stringent demand for the presence of a vacant
homolog in the databases. Importantly, these vacant
homologs facilitate the identiﬁcation of the target site of
each HEase. As the intron/intein insertion site marks the
target sequence of the resident HEase, we assigned each
HEase with a predicted target site composed of the DNA
sequences ﬂanking the inferred splice sites from the exon/
extein side (Figure 1). The exact boundaries of each target
could not be automatically predicted. HEase targets vary
in length and many are asymmetrically positioned with
respect to the intron/intein insertion site. As a partial
remedy, each HomeBase record holds seven codons 50
and seven codons 30 to the splice site, which is enough
to encompass the target of any characterized HEase.
Any predicted HEase target (e.g. in the human genome)
would align to a signiﬁcant and central subsequence of
these 14 codons, hopefully encompassing the true target
of the HEase (see ‘Materials and Methods’ section).
Importantly, HomeBase assigns each HEase not with a
target sequence but rather with a target range. As dis-
cussed above, an HEase encoded within a protein-coding
gene is expected to cleave many DNA sequences that have
the same translation as its native target (Figure 2). We,
therefore, use the amino acid translation of each target to
deﬁne the HEase target range, increasing the odds of
ﬁnding HEase targets in the human and other genomes
by several orders of magnitude. Our algorithm has
retrieved 416 unique target ranges for the 684 HEases
identiﬁed (Figure 3b).
After the ﬁrst translated BLAST used to identify
putative HEGs and the second translated BLAST used
to ﬁnd vacant homologs, we applied a third translated
BLAST to ﬁnd HEase targets of therapeutic or biotech-
nological uses. At this stage, the amino acid target ranges
are aligned to the targeted genome, human or other. First,
we searched for hits in and around human genes
associated with hereditary and other diseases, as listed in
NCBI’s OMIM database (http://www.ncbi.nlm.nih.gov/
omim). Importantly, the match in the human gene needs
not be in the translated reading frame of the target gene or
even on the sense strand. Moreover, a match in an intron
or in the 50-UTR can be equally useful (for inserting a
cDNA under the endogenous promoter but upstream to
the deleterious mutations).
Table 1 presents selected results of potential medical
use. The selection exempliﬁes the special emphasis that
we have given to those targets that were found in the
human genome as a result of genuine homology and con-
servation of the targeted protein motif from the native
microbe to humans: these targets are also found in the
homologous loci of animal models and are thus useful
for pre-clinical experiments.
For each human target the table indicates the thera-
peutic relevance, as well as the natural host species of
the HEase, the level of identity between the predicted
(translated) HEase target and the (translated) human
sequence, the classiﬁcation into HEase families, and an
estimate of the number of off-target cleavage sites in the
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list of the top 66 HomeBase hits in human genes is given in
Supplementary Table S2. These hits are mostly from
LAGLIDADG HEases (79%) and some GIY–YIG
(15%), HNH (3%) and His–Cys (3%). The number of
off-target cleavage sites for these HEases ranges from
0 to 112, with a median of 9.
We note that some HEases have targets only in
inter-genic human loci (Supplementary Figure S1). Some
of these loci may prove to be genomic safe harbors,
allowing for a stable, safe and efﬁcient transgene expres-
sion (e.g. for the treatment of recessive diseases). Finally,
the targets of many HEases in HomeBase diverge slightly
from a desired sequence (e.g. a disease-associated human
locus). These enzymes may be chosen as scaffolds for
enzyme engineering to achieve the necessary speciﬁcity
and efﬁcacy.
Validation of HomeBase predictions
When a putative HEase is found in an organism with
highly developed genetic tools, the activity of the
enzyme can be assayed in the native organism (44). For
example, HomeBase predicts that the PolB intein of the
halophilic archaeon H. volcanii encodes an active HEase.
Our prediction of the intein borders coincides with the
INBASE predictions (38). We have previously identiﬁed
its endonuclease domain and experimentally validated its
endonuclease activity. Using an archaeal plasmid assay,
we have also demonstrated that the H. volcanii HEase
can cleave its predicted target with high efﬁciency. The
assay involves transforming the archaeon with a plasmid
bearing the HEase target as an integral part of a PolB
vacant allele. When the plasmid enters the archaeal cell,
the endogenously expressed HEase can recognize and
cleave its target and induce intein homing into the
plasmid via homologous recombination (Figure 4a).
Intein homing can be detected by PCR ampliﬁcation
using target ﬂanking, plasmid-speciﬁc primers. In the
context of the present HomeBase gene targeting applica-
tion, we now substituted the native target of the enzyme
with its predicted target in the human homolog of PolB,
the DNA polymerase delta gene (PolD1, Figure 4b). We
ﬁnd that high cleavage efﬁciency is retained (Figure 4c and
d). We note that PolD1 in eukaryotes is involved in DNA
repair and that mutations in this gene in humans are
associated with colon cancer and with sporadic colorectal
carcinomas (45).
The H. volcanii HEase is a special case in that its activity
on the predicted human target could easily be assayed in
the natural host, because methods of genetic manipula-
tions are highly developed for this archaeal species. It
should also be noted that H. volcanii is halophilic and,
therefore, the enzyme is expected to have reduced
activity in human cells [although extremophilic HEases
can be readily adapted to mesophilic conditions by
genetic engineering (46)]. Therefore, we wanted to
develop a more robust validation method that would
allow us to verify the activity of HEases on their predicted
targets in a eukaryotic setting. Following Chames et al.
(47), we designed an assay in the budding yeast
S. cerevisiae, wherein the predicted HEase target is
inserted between the truncated repeats of the genes
encoding the metabolic enzymes Ura3 and Lys2. The
HEG is plasmid borne and is expressed from a
galactose-induced promoter. Upon HEase cleavage, the
truncated repeats recombine and reconstitute the metabol-
ic genes, allowing the yeast to grow on medium lacking
uracil and lysine (Figure 5a).
The intein encoded in the gene for the splicing factor
PRP8 of the fungus B. cinerea has recently been shown to
be an active HEase (35). According to the HomeBase
paradigm, this enzyme should be able to cleave the
PRP8 human homolog PRPF8, mutations in which
cause the progressive blindness disorder retinitis
pigmentosa (48). The amino acid sequences of the fungal
and human genes share a high degree of similarity, while
the nucleotide sequences have diverged (Figure 5b).
We designed two yeast constructs, one carrying the
native B. cinerea target between the truncated repeats of
the metabolic markers and the other carrying the pre-
dicted human target. Enzyme activity is highest for the
natural target but is also very high for the human target
[respectively:  1800- and  50-fold increase in efﬁcacy;
Figure 5c and Supplementary Figure S2 showing similar
Table 1. Selected results of medical signiﬁcance
Source of HEase
a HEase family Human gene Therapeutic relevance Target site identity
b Off-target hits
c
Botrytis cinerea LAGLIDADG PRPF8 Retinitis pigmentosa 11/11 0
Haloferax volcanii LAGLIDADG POLD1 Colon and colorectal cancer 9/10 0
Metagenomic LAGLIDADG FANCA Fanconi anemia 8/9 1
Metagenomic GIY–YIG LMNA Dilated cardiomyopathy 8/9 8
Trichodesmium erythraeum IMS101 LAGLIDADG SMAR-CAL1 Schimke immunoosseous dysplasia 11+1/12 14
Metagenomic LAGLIDADG VCP Inclusion body myopathy 10+1/12 1
Metagenomic LAGLIDADG CYP11B2 Low renin hypertension 8/8 3
Hypoaldosteronism
Metagenomic LAGLIDADG SPG7 Spastic paraplegia 7 9+1/11 3
aOften, a family of related HEases can each cleave the same given target. Here, we list representatives of such families. Our online database and
server http://homebase-search.tau.ac.il/, hold all members of such an HEase family, when relevant.
bX+Y/Z: X identities and Y similarities out of a Z amino acid long alignment between the translation of the indigenous target and the translation of
a putative target sequence in the human gene. An eight amino acids long sequence is predicted to be unique within a random sample of the size of the
six-frame translation of the human genome. The targets of many HEases are not longer than 8 3=24bp.
cOff-target hits: number of BLAST hits in the human genome whose E-value was less than 3 times worse (larger) than the E-value of the desired hit.
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mouse PRPF8 gene].
Botrytis cinerea is a fungus, as is the budding yeast.
However, the yeast assay can demonstrate the activity of
HEases from diverse phyla. We applied this assay
to cyanobacteria to demonstrate this ability. The
ribonucleotide reductase (RNR) of Nostoc species
PCC7120 encodes an intein with characteristic HEase
motifs. We used the yeast assay to evaluate the Nostoc
HEase activity on its predicted target. In spite of the
large phylogenetic distance between S. cerevisiae and
Nostoc, the cyanobacterial enzyme cleaved its predicted
target in yeast with extremely high efﬁciency (Figure 5d
and e). We note that cyanobacteria biotechnology is an
exponentially growing ﬁeld with implications in biofuel
production (49) and bioremediation (50,51). Many
Nostoc strains and species of related cyanobacteria
encode vacant RNR genes, lacking the intein and there-
fore possess an intact HEase target. While the nucleotide
sequences diverge between different species, the transla-
tion is highly conserved (Figure 5d). We found that the
cleavage efﬁciency of the HEase from Nostoc species
PCC7120 of targets from related species of proven bio-
technological value, such as N. punctiforme (52) and
Synechoccus (49) is as high or higher than its activity on
the endogenous target (Figure 5e). The Nostoc RNR
HEase exempliﬁes how the HomeBase paradigm could
and should be extended far beyond the scope of gene
therapy alone. Finally, we emphasize that both the
B. cinerea PRP8 HEase and the Nostoc RNR HEase
showed no signiﬁcant toxicity to the budding yeast
(Supplementary Figure S3) while being nearly as potent
as the I-SceI golden standard (Supplementary Figure S4).
This result demonstrates the exquisite speciﬁcity of these
enzymes, because even a single un-repaired DSB is strictly
lethal in S. cerevisiae (53).
DISCUSSION
Attempts to engineer HEases for gene targeting have so
far focused on a small group of enzymes (54), while the
plethora and diversity of native HEases have been
V A Y G D T D S V M
Native target  GTG GCC TAC GGC GAC ACC GAC AGC GTC ATG
H. sapiens GTG GTG TAT GGT GAC ACT GAC TCC GTC ATG
(a)
(b)
(c)
(d)
After homing: 
Long PCR products
Before or 
without homing: 
Short PCR products
Colony No.  1  2  3  4  5  6  7  8  9  10
kb
3
2
1.5
1
0.75
H. Volcanii POLB locus
Replicating plasmid
Figure 4. The PolB HEase of H. volcanii can cleave a target sequence from the human gene PolD1. (a) A PCR is preformed on H. volcanii individual
colonies transformed with a plasmid bearing a vacant PolB allele coding either the native target of the PolB HEase or a homologous sequence from
the human PolD1 gene. The PCR reaction (white arrows denote primers) can amplify either a short product in the absence of homing or a long
product if homing has taken place. (b) Nucleotide and amino acid alignments of the target sequence from the H. volcanii PolB gene and the
homologous human sequence from the PolD1 gene. (c) Representative results of the PCR assay in cells carrying a plasmid with the human target
sequence. A long PCR product indicates that homing has occurred. (d) The relative homing efﬁciency of the PolB HEase to the plasmid-borne vacant
homolog carrying either native (archaeal) or human targets, or no target (n=30). Error bars represent 95% conﬁdence intervals based on Monte
Carlo simulations.
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Figure 5. A yeast assay demonstrating the activity of different HEases on their native targets as well as on targets of therapeutic or biotechnological
uses. (a) The yeast assay for HEase activity [Following Chames et al. (48)]. An HEase target site is inserted between truncated Ura3 repeats and
between truncated Lys2 repeats. Upon HEase cleavage a recombination event reconstitutes the respective metabolic markers. (b and c) The B. cinerea
PRP8 HEase can cleave the human PRPF8 gene. (b) Nucleotide alignment of the B. cinerea PRP8 HEase-target and the homologous sequence from
the human PRPF8 gene. The asterisk indicates that the adenine (green A) in the human sequence is the last nucleotide of an intron. The cDNA of
human PRPF8 has a thymidine at this position (and is part of a tryptophan codon—W). The target used in our assay has adenine to show cleavage
of the genomic sequence. (c) Relative activity of the B. cinerea PRP8 HEase on its native target and on its human target from the PRPF8 gene (log
scale). Relative activity is the ratio between the growth rates of strains with or without the HEase-expressing plasmid. (d and e) The Nostoc RNR
HEase can cleave its predicted target as well as targets in related cyanobacteria of biotechnological use. (d) Nucleotide alignment of the Nostoc
species PCC7120 RNR HEase-target and the homologous sequence from the RNR genes of N. punctiforme and Synechococcus. (e) Relative activity
of the Nostoc species PCC7120 RNR HEase on its native target and on sequences from the RNR genes of N. punctiforme and Synechococcus (log
scale). Error bars represent 95% conﬁdence intervals based on Monte Carlo simulations. N. punctiforome, Nostoc punctiforome.
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approximately a thousand different HEases alongside
their predicted targets. The computational pipeline de-
veloped here is a set of tailor-made methods for HEase
discovery and characterization that rely on their unique
biological and evolutionary properties: the presence of
vacant homologs, their setting within introns/inteins,
and their predictable tolerance for silent mutations in
their target sequences.
Enzyme engineering can now begin by choosing a
scaffold HEase whose target is most similar to the
sequence at the target locus of choice. We have also
developed methods for preliminary validation of HEase
activity in a eukaryotic setting. Candidate screening in
yeast can help in the detection of degenerated HEases
that are naturally common (13,55,56). Notably, evolution-
ary considerations may sometime only help to approxi-
mate the intricacies of enzyme speciﬁcity, as can be
revealed, for example, by yeast surface display (57) or by
cleavage assays with large randomized target libraries (23).
When suboptimal speciﬁcity is revealed, the yeast selection
system can be used for directed evolution of selected
HEases (58). However, we have shown here that native
HEases could sometimes themselves be used for the gene
targeting of disease-associated genes and genes of biotech-
nological relevance. HEases possess exquisite speciﬁcity
that has evolved through billions of years. The long
target sequences of HEases allow the recognition of
unique sites while considerations of sequence conservation
allow an approximation of the plasticity in target recog-
nition. In particular, for those HEases that reside in
protein-coding genes, we have established that a translated
BLAST could be used to ﬁnd cleavable targets in the
human and other genomes. Even when an HEase has
more than a single target in a genome of choice, the
off-target effect may be conﬁned and predictable based
on evolutionary considerations. This predictability is
however limited as some tolerance of non-synonymous
substitutions can be expected (21,23).
We believe that the safety concerns regarding the use of
site-speciﬁc endonucleases in gene therapy are well
addressed by native HEases. This is all the more true for
a subgroup of HEases whose predicted human targets are
found in homologs of the microbial HEase-hosting gene.
These enzymes are shown to cleave the same locus in
humans and in any animal model of choice (Figure 2c
and d), thus facilitating pre-clinical efﬁcacy and safety
assessments. The Nostoc RNR exempliﬁes how such
enzymes could also be used in the biotechnology
industry. In this study we focused on members of the
LAGLIADG HEase family, comprising  80% of all
HEases. Future studies should test the applicability of
our conclusions to all HEases as may be implied by
previous reports (28,29). Finally, the genes for native
HEases are readily available and can be incorporated
in therapeutic and other vectors with relative ease and
low costs compared to the engineered alternative.
We therefore believe that the under-recognized diver-
sity and plasticity of native HEases should become a
valuable tool in the ﬁelds of gene therapy and genetic
engineering.
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